Ultrahuman has expanded its metabolic health offering in the United States with M2 Live, a platform built around real-time glucose monitoring and AI-driven analysis. The move makes glucose tracking more accessible by using Abbott’s Lingo continuous glucose monitor without requiring a doctor’s prescription.
That shift matters because the service is not positioned only for people with a medical need to watch blood sugar. It is aimed at adults aged 18 and older who do not use insulin, offering a way to understand how ordinary habits shape metabolic health.
How the platform reads the body in real time
M2 Live centers on continuous glucose data throughout the day, allowing users to see how their levels change as they eat, move, sleep, and deal with stress. The idea is to connect the numbers on the screen with the routines that influence them.
Ultrahuman says the system includes a clinically validated Metabolic Score that measures glucose regulation on a daily basis. The score is designed to turn raw readings into a clearer picture of how the body is responding over time.
Another layer comes from Jade AI, the company’s biointelligence system, which converts health data into recommendations that users can act on. Those recommendations focus on nutrition, activity, and recovery rather than isolated readings.
More than glucose alerts
The platform also adds glucose spike alerts, Food Score, and Fueling Score to give users more personalized guidance around meals and exercise. These tools are intended to show which foods or routines may be linked to sharper glucose changes.
Ultrahuman has also opened access to OGDb, an open database of anonymous food and glucose responses drawn from its community. That layer gives users broader context when comparing their own patterns with aggregated behavioral data.
The result is a system that goes beyond basic tracking. It aims to help users adjust habits based on patterns that become visible only when food, movement, and recovery are measured together.
Linking glucose with sleep, recovery, and biomarker data
M2 Live can connect with the Ultrahuman Ring, bringing sleep patterns, activity levels, recovery metrics, heart rate variability, and skin temperature into the same view. That integration helps place glucose fluctuations alongside other signals that affect how the body feels and performs.
For members of Ultrahuman’s Blood Vision program, the analysis goes further. They can view glucose data next to more than 100 blood biomarkers, creating a more detailed picture of overall health.
This broader integration is important because glucose data alone can be hard to interpret in isolation. When it sits next to sleep quality, physical load, or recovery trends, the patterns become easier to understand.
Research support and U.S. availability
Ultrahuman says the platform is supported by research collaborations with Stanford University, Bangor University, La Trobe University, and Mayo Clinic. Some of those studies are still ongoing, which the company presents as part of the product’s scientific foundation.
The service is currently limited to the United States and will be available through Ultrahuman’s official website in the coming weeks. For now, the rollout remains focused on the U.S. market only.
Pricing in the U.S. is set at $129 for one sensor, while the monthly subscription costs $99. Each supported Abbott Lingo sensor can be used for up to 14 days before replacement is needed.
That combination of real-time glucose monitoring, AI analysis, and broader health integration shows where Ultrahuman is pushing next. M2 Live is built to turn day-to-day data into a more practical view of metabolic behavior.
